ISPOR - POSC141 Evaluation of the Long-Term Cost-Effectiveness of Ideglira Versus Liraglutide for Patients with Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs in China

POSC141 Evaluation of the Long-Term Cost-Effectiveness of Ideglira Versus Liraglutide for Patients with Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs in China

Abstract

Authors

RX Jia

Full Text Cite This Article

Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now